Pluristem Therapeutics

+$0.18 (+7.29%) Today
-$0.05 (-1.89%) As of 10:55 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PSTI and other ETFs, options, and stocks.

About PSTI

Pluristem Therapeutics, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions.

CEO
Yaky Yanay
Employees
153
Headquarters
Haifa, Haifa
Founded
2001

PSTI Key Statistics

Market Cap
84.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
118.75K
High Today
$2.67
Low Today
$2.49
Open Price
$2.53
Volume
182.77K
52 Week High
$11.85
52 Week Low
$2.44

PSTI Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure